CDG Invest Growth (CIG), the private equity fund manager previously known as CDG Capital Private Equity, and Techniques Science-Santé (T2S) have announced the finalisation of the sale of the latter to a Helios Investment Partners fund.

Helios acquired a majority stake in the largest and most diversified group of medtech companies in Morocco. The consolidated group operates in medical devices, in vitro diagnostic and pharmaceuticals, and comprises four companies: T2S, IM Alliance, Cycl...